Venous thromboembolic disease.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it.

1. Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia.The Cochrane database of systematic reviews · 2020
   Pooled it
2. Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis.PLoS medicine · 2012
   Pooled it
3. Clinical applications of PET imaging for evaluating treatment-induced vascular toxicity in oncology.Current opinion in hematology · 2026
   Review
4. An Overview of Anticoagulant Drugs Pharmacology, Therapeutic Approaches, Limitations and Perspectives.Pharmaceutics · 2026
   Review
5. Recent Advances in the Management of Cancer-Associated Thrombosis: New Hopes but New Challenges.Cancers · 2019
   Review
6. Could sodium imbalances predispose to postoperative venous thromboembolism? An analysis of the NSQIP database.Thrombosis journal · 2018
   Article
7. Thrombosis in Thyroid Cancer.International journal of endocrinology and metabolism · 2018
   Review
8. Venous Thromboembolism in Children with Cancer and Blood Disorders.Frontiers in pediatrics · 2017
   Review
9. Risk of venous thromboembolism in people with lung cancer: a cohort study using linked UK healthcare data.British journal of cancer · 2016
   Article
10. Pattern of Venous Thromboembolism Occurrence in Gynecologic Malignancy: Incidence, Timing, and Distribution a 10-Year Retrospective Single-institutional Study.Medicine · 2015
    Observational
11. Structural analysis and anticoagulant activities of the novel sulfated fucan possessing a regular well-defined repeating unit from sea cucumber.Marine drugs · 2015
    Article
12. Inferior vena cava filters: current best practices.Journal of thrombosis and thrombolysis · 2015
    Review
13. Venous thromboembolism in children with cancer - a population-based cohort study.Thrombosis research · 2014
    Article
14. Comparison of physicochemical characteristics and anticoagulant activities of polysaccharides from three sea cucumbers.Marine drugs · 2013
    Article
15. Venous thromboembolism risk in patients with cancer receiving chemotherapy: a real-world analysis.The oncologist · 2013
    Article
16. Thromboprophylaxis guidelines in cancer with a primary focus on ambulatory patients receiving chemotherapy: a review from the Southern Network on Adverse Reactions (SONAR).Seminars in thrombosis and hemostasis · 2012
    Review
17. A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score.Internal and emergency medicine · 2012
    Article
18. Emerging Insights of Management of Venous Thromboembolism in Patients With Cancer.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

22 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as